Technical Analysis for RHT - Resonance Health Limited  

Grade Last Price % Change Price Change
A 0.081 -4.71% -0.004
RHT closed down 4.71 percent on Monday, April 29, 2024, on 62 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Flat

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction -4.71%
Stochastic Reached Overbought Strength -4.71%
Wide Bands Range Expansion -4.71%
Overbought Stochastic Strength -4.71%
New 52 Week Closing High Bullish -4.71%
Narrow Range Bar Range Contraction -4.71%
Wide Bands Range Expansion -4.71%
Gapped Up Strength -4.71%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 20 hours ago
Down 3% about 20 hours ago
Down 2% about 20 hours ago
Down 1% about 20 hours ago
Gapped Up (Full) 6 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Resonance Health Limited   Description

Resonance Health Limited is principally engaged in the development and commercialization of technologies and services for the quantitative analysis of radiological images. The Company's segments include Services, Research and Development, and Corporate. The Company's core product is FerriScan, which is a non-invasive liver diagnostic technology used for the measurement of iron in the liver. FerriScan is used for liver iron concentration (LIC) measurement from magnetic resonance imaging (MRI) scans of a patient's liver. The FerriScan analysis procedure produces a mean LIC measurement and a color coded map reflecting the iron distribution across the liver. The Company's product HepaFat-Scan, is a non-invasive method for measuring volumetric liver fat fraction (VLFF) from MRI scans. HepaFat-Scan is provided as an image analysis service. HepaFat-Scan is available for routine clinical use and for use in pharmaceutical company clinical trials.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Health Iron Medicine Pharmaceutical Radio Imaging Clinical Trial Medical Imaging Measurement Medical Equipment Radiology Medical Physics Volume Magnetic Resonance Imaging Mri Physics

Is RHT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.088
52 Week Low 0.037
Average Volume 257,160
200-Day Moving Average 0.057
50-Day Moving Average 0.065
20-Day Moving Average 0.077
10-Day Moving Average 0.081
Average True Range 0.004
RSI (14) 60.47
ADX 52.64
+DI 46.644
-DI 18.589
Chandelier Exit (Long, 3 ATRs) 0.075
Chandelier Exit (Short, 3 ATRs) 0.073
Upper Bollinger Bands 0.088
Lower Bollinger Band 0.065
Percent B (%b) 0.69
BandWidth 29.765
MACD Line 0.005
MACD Signal Line 0.005
MACD Histogram 0.0
Fundamentals Value
Market Cap 36.03 Million
Num Shares 445 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 27.00
Price-to-Sales 18.86
Price-to-Book 7.18
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.087
Resistance 3 (R3) 0.088 0.086 0.086
Resistance 2 (R2) 0.086 0.085 0.086 0.086
Resistance 1 (R1) 0.084 0.084 0.083 0.083 0.085
Pivot Point 0.082 0.082 0.082 0.082 0.082
Support 1 (S1) 0.080 0.081 0.079 0.079 0.077
Support 2 (S2) 0.078 0.080 0.078 0.076
Support 3 (S3) 0.076 0.078 0.076
Support 4 (S4) 0.075